South Korea's insurance firms posted a net profit of 6.08 trillion won last year, up by 742 billion won or 13.9 percent, partly due to fewer car accidents as more people stayed home.
The net profit of life insurance companies increased 10.9 percent to 3,454.4 billion won, while those of non-life firms rose 8.1 percent to 2,626.2 billion won.
According to data from the Financial Supervisory Service (FSS), loss ratios for auto insurance and long-term insurance improved due to decreasing the number of car accidents and hospital treatment cases.
Insurance income rose as guarantee reserves decreased and savings-type insurance sales went up compared with a year ago.
Last year, insurance firms posted a 221.9 trillion won premium income, up 4.3 percent from 2019.


Anta Sports Expands Global Footprint With Strategic Puma Stake
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Washington Post Publisher Will Lewis Steps Down After Layoffs
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



